SherMATRIX Inc.

medical devices

About

SherMATRIX Inc. is a spin-off company of the U. of Sherbrooke (Faculty of Engineering). The company's general goal is to find practical solutions to unmet needs identified by surgeons and other members of the overall medical community. Our first product is a new and powerful biosealant (bioglue) derived from the extracellular matrix (ECM) of animal organs/tissues. The new biosealant has shown tremendous potential in initial tests for sealing air leaks following pulmonary surgeries. Other applications using either the new biosealant or variations of it are being developed for solving other problems (liver, skeletal muscles, chronic ulcers, etc.). SherMATRIX Inc. presently belongs to two shareholders: Dr. Patrick Vermette and Dr. Denis Groleau. In 2020, SherMATRIX has obtained a research grant for pursuing the development of the new biosealant so that future homologation of the product will be faciliated. The company is actively looking for private investors or patient venture capital to support its long-term development.

Technologies

Google Cloud Hosting WordPress.org Mobile Friendly Nginx Google Font API

Keywords

formulation extraction biosealant cell culture product characteriation extracellular matrix medical equipment manufacturing biomaterial customization bioprosthetic scaffolds collaborations with surgeons biotechnology biomaterials development stem cell therapy cell culture support biotechnological engineering medical equipment and supplies manufacturing in vivo validation healthcare bioreactor for cell culture medical applications animal-derived ecm stem cells cell therapy support scaffolds chronic ulcer treatment biomaterials bioadhesive organ decellularization tissue engineering animal origin biomaterials

Location

Sherbrooke, Quebec, Canada

Related Companies

Companies in the same industry